Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3817166rdf:typepubmed:Citationlld:pubmed
pubmed-article:3817166lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:3817166lifeskim:mentionsumls-concept:C0031308lld:lifeskim
pubmed-article:3817166lifeskim:mentionsumls-concept:C0002475lld:lifeskim
pubmed-article:3817166lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:3817166lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:3817166lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3817166lifeskim:mentionsumls-concept:C2700289lld:lifeskim
pubmed-article:3817166pubmed:issue1lld:pubmed
pubmed-article:3817166pubmed:dateCreated1987-4-16lld:pubmed
pubmed-article:3817166pubmed:abstractTextThe drugs in the FAM combination (fluorouracil, doxorubicin, mitomycin) were tested for a possible effect on monocyte function by means of a glass-surface fluorescence-quenching technique of monocyte phagocytosis. The individual drugs significantly inhibited monocyte phagocytosis. The inhibition was located at the engulfment phase of phagocytosis and in an order of magnitude of 20-30%. The FAM combination did not suppress monocyte phagocytosis more than each one of the individual drugs. It is suggested that a slight inhibition of monocyte phagocytosis is a cost of cytotoxic treatment.lld:pubmed
pubmed-article:3817166pubmed:languageenglld:pubmed
pubmed-article:3817166pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3817166pubmed:citationSubsetIMlld:pubmed
pubmed-article:3817166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3817166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3817166pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3817166pubmed:statusMEDLINElld:pubmed
pubmed-article:3817166pubmed:monthFeblld:pubmed
pubmed-article:3817166pubmed:issn0748-7983lld:pubmed
pubmed-article:3817166pubmed:authorpubmed-author:DomellöfLLlld:pubmed
pubmed-article:3817166pubmed:authorpubmed-author:NorbergBBlld:pubmed
pubmed-article:3817166pubmed:authorpubmed-author:AthlinLLlld:pubmed
pubmed-article:3817166pubmed:issnTypePrintlld:pubmed
pubmed-article:3817166pubmed:volume13lld:pubmed
pubmed-article:3817166pubmed:ownerNLMlld:pubmed
pubmed-article:3817166pubmed:authorsCompleteYlld:pubmed
pubmed-article:3817166pubmed:pagination51-5lld:pubmed
pubmed-article:3817166pubmed:dateRevised2007-7-2lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:meshHeadingpubmed-meshheading:3817166-...lld:pubmed
pubmed-article:3817166pubmed:year1987lld:pubmed
pubmed-article:3817166pubmed:articleTitlePhagocytosis of yeast cells by monocytes: effects of fluorouracil, doxorubicin and mitomycin.lld:pubmed
pubmed-article:3817166pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3817166pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3817166pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed